Effect of Olanzapine and Risperidone on clinical and biochemical profile of persons with Schizophrenia.
Not Applicable
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2023/01/049307
- Lead Sponsor
- Government Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Diagnosis of schizophrenia according to ICD-11
Drug naïve or not on any antipsychotic drug from past 4 weeks
Exclusion Criteria
Patients with co-morbid substance dependence (except nicotine and caffeine)
Patients who are lactating or pregnant.
Patients with any unstable medical (hypothyroidism, diabetes insipidus, kidney disease, liver disease, chronic heart disease) neurological or surgical disorders.
Patients with history of active infection in last 2 weeks.
Patients with history of autoimmune diseases.
Patients on any immunosuppressant drug.
Acutely suicidal patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method